Cargando…
In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study
BACKGROUND: Increased antibiotic resistance against Staphylococcus aureus and low penetration into bone requires regimen optimization of available drugs. METHODS: We evaluate pharmoacokinetic and pharmacodynamic parameters (PK/PD) as well as in vivo interactions of continuous flucloxacillin 12 g/d a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072877/ https://www.ncbi.nlm.nih.gov/pubmed/25019039 http://dx.doi.org/10.1186/2193-1801-3-287 |
_version_ | 1782323029322235904 |
---|---|
author | Garzoni, Christian Uçkay, Ilker Belaieff, Wilson Breilh, Dominique Suvà, Domizio Huggler, Elzbieta Lew, Daniel Hoffmeyer, Pierre Bernard, Louis |
author_facet | Garzoni, Christian Uçkay, Ilker Belaieff, Wilson Breilh, Dominique Suvà, Domizio Huggler, Elzbieta Lew, Daniel Hoffmeyer, Pierre Bernard, Louis |
author_sort | Garzoni, Christian |
collection | PubMed |
description | BACKGROUND: Increased antibiotic resistance against Staphylococcus aureus and low penetration into bone requires regimen optimization of available drugs. METHODS: We evaluate pharmoacokinetic and pharmacodynamic parameters (PK/PD) as well as in vivo interactions of continuous flucloxacillin 12 g/d administration combined with high dose oral rifampicin 600 mg bid in the serum of 15 adult patients with bone and soft tissue infections. We use the patient’s own serum directed against his own isolated S. aureus strain to reproduce in vivo conditions as closely as possible. RESULTS: The continuous flucloxacillin infusion constantly generated plasma free drug levels largely exceeding the serum minimal inhibitory concentrations (mean 74-fold). Combination with rifampicin significantly increased flucloxacillin levels by 44.5%. Such an increase following rifampicin introduction was documented in 10/15 patients, whereas a decrease was observed in 1/15 patients. Finally, all infections were cured and the combination was well tolerated. CONCLUSIONS: In this in vivo methodological pilot study among adult patients with orthopaedic infections due to S. aureus, we describe a new method and reveal substantial but inconsistent interactions between flucloxacillin and rifampicin, of which the clinical significance remains unclear. |
format | Online Article Text |
id | pubmed-4072877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-40728772014-07-11 In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study Garzoni, Christian Uçkay, Ilker Belaieff, Wilson Breilh, Dominique Suvà, Domizio Huggler, Elzbieta Lew, Daniel Hoffmeyer, Pierre Bernard, Louis Springerplus Research BACKGROUND: Increased antibiotic resistance against Staphylococcus aureus and low penetration into bone requires regimen optimization of available drugs. METHODS: We evaluate pharmoacokinetic and pharmacodynamic parameters (PK/PD) as well as in vivo interactions of continuous flucloxacillin 12 g/d administration combined with high dose oral rifampicin 600 mg bid in the serum of 15 adult patients with bone and soft tissue infections. We use the patient’s own serum directed against his own isolated S. aureus strain to reproduce in vivo conditions as closely as possible. RESULTS: The continuous flucloxacillin infusion constantly generated plasma free drug levels largely exceeding the serum minimal inhibitory concentrations (mean 74-fold). Combination with rifampicin significantly increased flucloxacillin levels by 44.5%. Such an increase following rifampicin introduction was documented in 10/15 patients, whereas a decrease was observed in 1/15 patients. Finally, all infections were cured and the combination was well tolerated. CONCLUSIONS: In this in vivo methodological pilot study among adult patients with orthopaedic infections due to S. aureus, we describe a new method and reveal substantial but inconsistent interactions between flucloxacillin and rifampicin, of which the clinical significance remains unclear. Springer International Publishing 2014-06-07 /pmc/articles/PMC4072877/ /pubmed/25019039 http://dx.doi.org/10.1186/2193-1801-3-287 Text en © Garzoni et al.; licensee Springer. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Garzoni, Christian Uçkay, Ilker Belaieff, Wilson Breilh, Dominique Suvà, Domizio Huggler, Elzbieta Lew, Daniel Hoffmeyer, Pierre Bernard, Louis In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study |
title | In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study |
title_full | In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study |
title_fullStr | In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study |
title_full_unstemmed | In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study |
title_short | In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study |
title_sort | in vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to staphylococcus aureus - a methodological and pilot study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072877/ https://www.ncbi.nlm.nih.gov/pubmed/25019039 http://dx.doi.org/10.1186/2193-1801-3-287 |
work_keys_str_mv | AT garzonichristian invivointeractionsofcontinuousflucloxacillininfusionandhighdoseoralrifampicinintheserumof15patientswithboneandsofttissueinfectionsduetostaphylococcusaureusamethodologicalandpilotstudy AT uckayilker invivointeractionsofcontinuousflucloxacillininfusionandhighdoseoralrifampicinintheserumof15patientswithboneandsofttissueinfectionsduetostaphylococcusaureusamethodologicalandpilotstudy AT belaieffwilson invivointeractionsofcontinuousflucloxacillininfusionandhighdoseoralrifampicinintheserumof15patientswithboneandsofttissueinfectionsduetostaphylococcusaureusamethodologicalandpilotstudy AT breilhdominique invivointeractionsofcontinuousflucloxacillininfusionandhighdoseoralrifampicinintheserumof15patientswithboneandsofttissueinfectionsduetostaphylococcusaureusamethodologicalandpilotstudy AT suvadomizio invivointeractionsofcontinuousflucloxacillininfusionandhighdoseoralrifampicinintheserumof15patientswithboneandsofttissueinfectionsduetostaphylococcusaureusamethodologicalandpilotstudy AT hugglerelzbieta invivointeractionsofcontinuousflucloxacillininfusionandhighdoseoralrifampicinintheserumof15patientswithboneandsofttissueinfectionsduetostaphylococcusaureusamethodologicalandpilotstudy AT lewdaniel invivointeractionsofcontinuousflucloxacillininfusionandhighdoseoralrifampicinintheserumof15patientswithboneandsofttissueinfectionsduetostaphylococcusaureusamethodologicalandpilotstudy AT hoffmeyerpierre invivointeractionsofcontinuousflucloxacillininfusionandhighdoseoralrifampicinintheserumof15patientswithboneandsofttissueinfectionsduetostaphylococcusaureusamethodologicalandpilotstudy AT bernardlouis invivointeractionsofcontinuousflucloxacillininfusionandhighdoseoralrifampicinintheserumof15patientswithboneandsofttissueinfectionsduetostaphylococcusaureusamethodologicalandpilotstudy |